Literature DB >> 16699166

Stearylated octaarginine and artificial virus-like particles for transfection of siRNA into primary rat neurons.

Lars Tönges1, Paul Lingor, Roman Egle, Gunnar P H Dietz, Alfred Fahr, Mathias Bähr.   

Abstract

RNA interference (RNAi) provides a powerful experimental tool for sequence-specific gene silencing, allowing efficient analysis of gene function in a multitude of cell types. However, application of RNAi in primary mammalian neurons has been limited by low-transfection efficiency and considerable toxicity of conventional transfection methods. In this study, we evaluated a peptide-mediated and a polymer/lipid-based cellular delivery method for siRNA into rat primary neurons and compared the results with a commonly used liposomal transfection reagent. Stearylated octaarginine (Stearyl-R8) was used as polypeptide and artificial virus-like particles (AVPs) were used as a combined liposomal-polymeric vector, since both reagents have been previously shown to successfully transfect DNA into cell lines. Stearyl-R8 and AVPs both promoted siRNA transfection into primary hippocampal neurons via the endosomal pathway. SiRNA-mediated gene silencing could be effectively induced in primary neuron cultures. In comparison with the commonly used cationic liposome transfection agent, both novel reagents were less detrimental to cell metabolic activity. We conclude that these novel transfection methods yield performances comparable to cationic liposome-mediated transfection for siRNA, while being less cytotoxic in primary neurons. Stearyl-R8 and AVPs may therefore represent novel and more cost-efficient alternatives to conventional siRNA-transfection reagents.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16699166      PMCID: PMC1484438          DOI: 10.1261/rna.2252206

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  22 in total

1.  Highly efficient transduction of endothelial cells by targeted artificial virus-like particles.

Authors:  K Müller; T Nahde; A Fahr; R Müller; S Brüsselbach
Journal:  Cancer Gene Ther       Date:  2001-02       Impact factor: 5.987

2.  Combined transductional and transcriptional targeting of melanoma cells by artificial virus-like particles.

Authors:  T Nahde; K Müller; A Fahr; R Müller; S Brüsselbach
Journal:  J Gene Med       Date:  2001 Jul-Aug       Impact factor: 4.565

3.  RNA interference in human cells is restricted to the cytoplasm.

Authors:  Yan Zeng; Bryan R Cullen
Journal:  RNA       Date:  2002-07       Impact factor: 4.942

4.  RNAi functions in cultured mammalian neurons.

Authors:  Anna M Krichevsky; Kenneth S Kosik
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-21       Impact factor: 11.205

5.  Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells.

Authors:  Aleksandra Muratovska; Michael R Eccles
Journal:  FEBS Lett       Date:  2004-01-30       Impact factor: 4.124

6.  Stearylated arginine-rich peptides: a new class of transfection systems.

Authors:  S Futaki; W Ohashi; T Suzuki; M Niwa; S Tanaka; K Ueda; H Harashima; Y Sugiura
Journal:  Bioconjug Chem       Date:  2001 Nov-Dec       Impact factor: 4.774

Review 7.  Synthetic DNA delivery systems.

Authors:  D Luo; W M Saltzman
Journal:  Nat Biotechnol       Date:  2000-01       Impact factor: 54.908

8.  Highly branched HK peptides are effective carriers of siRNA.

Authors:  Qixin Leng; Puthupparampil Scaria; Jingsong Zhu; Nicholas Ambulos; Patricia Campbell; A James Mixson
Journal:  J Gene Med       Date:  2005-07       Impact factor: 4.565

9.  Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery.

Authors:  S Futaki; T Suzuki; W Ohashi; T Yagami; S Tanaka; K Ueda; Y Sugiura
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

10.  Activation of the interferon system by short-interfering RNAs.

Authors:  Carol A Sledz; Michelle Holko; Michael J de Veer; Robert H Silverman; Bryan R G Williams
Journal:  Nat Cell Biol       Date:  2003-08-24       Impact factor: 28.824

View more
  25 in total

1.  Highly potent inhibitors of proprotein convertase furin as potential drugs for treatment of infectious diseases.

Authors:  Gero L Becker; Yinghui Lu; Kornelia Hardes; Boris Strehlow; Christine Levesque; Iris Lindberg; Kirsten Sandvig; Udo Bakowsky; Robert Day; Wolfgang Garten; Torsten Steinmetzer
Journal:  J Biol Chem       Date:  2012-04-26       Impact factor: 5.157

Review 2.  Transfection techniques for neuronal cells.

Authors:  Daniela Karra; Ralf Dahm
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

3.  Cell-Penetrating Peptides Delivering siRNAs: An Overview.

Authors:  Luca Falato; Maxime Gestin; Ülo Langel
Journal:  Methods Mol Biol       Date:  2021

4.  Prevention of alveolar bone loss in an osteoporotic animal model via interference of semaphorin 4d.

Authors:  Y Zhang; L Wei; R J Miron; Q Zhang; Z Bian
Journal:  J Dent Res       Date:  2014-09-24       Impact factor: 6.116

5.  Preconditioning stimuli induce autophagy via sphingosine kinase 2 in mouse cortical neurons.

Authors:  Rui Sheng; Tong-Tong Zhang; Valeria D Felice; Tao Qin; Zheng-Hong Qin; Charles D Smith; Ellen Sapp; Marian Difiglia; Christian Waeber
Journal:  J Biol Chem       Date:  2014-07-25       Impact factor: 5.157

Review 6.  Functional peptides for siRNA delivery.

Authors:  Wanyi Tai; Xiaohu Gao
Journal:  Adv Drug Deliv Rev       Date:  2016-08-13       Impact factor: 15.470

7.  Click-modified cyclodextrins as nonviral vectors for neuronal siRNA delivery.

Authors:  A M O'Mahony; B M D C Godinho; J Ogier; M Devocelle; R Darcy; J F Cryan; C M O'Driscoll
Journal:  ACS Chem Neurosci       Date:  2012-08-03       Impact factor: 4.418

8.  Development of cholesteryl peptide micelles for siRNA delivery.

Authors:  Bin Qin; Zhijin Chen; Wei Jin; Kun Cheng
Journal:  J Control Release       Date:  2013-08-19       Impact factor: 9.776

9.  Recent developments in peptide-based nucleic acid delivery.

Authors:  Sandra Veldhoen; Sandra D Laufer; Tobias Restle
Journal:  Int J Mol Sci       Date:  2008-07-16       Impact factor: 6.208

Review 10.  Peptide-mediated cellular delivery of oligonucleotide-based therapeutics in vitro: quantitative evaluation of overall efficacy employing easy to handle reporter systems.

Authors:  S D Laufer; T Restle
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.